14122022 Nick Anderton Statement

Following the recent announcement regarding Nick Anderton and his diagnosis of Osteosarcoma, a rare form of bone cancer, the club would like to provide an update.

Nick, 26, underwent a successful operation on Wednesday 5th October to remove the tumorous area.
Following this operation, the tumour was sent off for further analysis and the biopsy revealed that the cancerous cells were more aggressive than previously thought. Due to this, Nick was informed that he would require chemotherapy treatment. This process has now begun and will last several months.
JMP_Bristol Rovers Training-AC_037 (1).JPG
Obviously, this has come as a shock to Nick and his family, and the club would like to reiterate its unwavering support for him.
CEO Tom Gorringe said: “As a club, we are extremely close so, when we hear news like we have received with Nick, it affects everyone. Sadly, the prognosis Nick has received has developed over the past few months, but we are all incredibly thankful that it was uncovered as early as it was and that he has been afforded such great care and support early on.
“Nick remains an integral part of our squad and everyone has remained in constant contact with him to offer our support and to do what we can to try and help him and his family through this difficult time.
JMP_Rovers_vs_Forest_Green_AW_002 (1).jpg
“Nick’s response and positivity, despite the adversity he is currently facing, is admirable and he is an inspiration to us all. I have no doubt that he will tackle his chemotherapy like he has the various hurdles that have been placed in front of him already and we look forward to welcoming him back to The Mem once his course has finished.
Nick said: “I would like to thank my family, friends, fans, teammates and the whole football community for their support - it means the world to me.”
Read Time: 2 mins